Table of Contents



SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

April 15, 2002


(Date of earliest event reported)

MEDICAL DISCOVERIES, INC.


(Exact name of registrant as specified in its charter)
         
Utah   0-12627   87-0407858

 
 
(State or other jurisdiction of
incorporation or organization)
  (Commission File No.)   (I.R.S. Employer
Identification No.)

738 Aspenwood Lane
Twin Falls, Idaho 83301
(208) 736-1799


(Address of principal executive offices and telephone number, including area code)



 


TABLE OF CONTENTS

Item 9. Regulation FD Disclosure
SIGNATURES
INDEX OF EXHIBITS
EXHIBIT 99


Table of Contents

Item 9. Regulation FD Disclosure

     This Current Report on Form 8-K is filed for the purpose of disclosing the press release that was released on April 15, 2002 and is attached hereto as Exhibit 99.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  MEDICAL DISCOVERIES, INC.

  /s/ Judy Robinett
Judy Robinett
Chief Executive Officer

Date: April 15, 2002

2


Table of Contents

INDEX OF EXHIBITS

     
Number   Description

 
99   Press Release issued April 15, 2002

3